Current status of FK 506 in liver transplantation.

A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase

1989 • 1,376 citations

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

1987 • 1,209 citations

Liver, Kidney, and Thoracic Organ Transplantation Under FK 506

1990 • 252 citations

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.

1988 • 160 citations

A highly sensitive method to assay FK-506 levels in plasma.

1987 • 149 citations

Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.

1987 • 136 citations

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.

1990 • 108 citations

SUPPRESSION OF ALLOGRAFT REJECTION WITH FK506

1990 • 79 citations

Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506.

1990 • 40 citations

Pathologic observations in human allograft recipients treated with FK 506.

1990 • 34 citations

FK 506 as a growth control factor.

1990 • 34 citations

Studies of the hepatotrophic qualities of FK 506 and CyA.

1990 • 20 citations

Complications of sclerotherapy for esophageal varices in liver transplant candidates.

1990 • 6 citations